SLITRK2
protein-codingSLIT and NTRK like family member 2, the group of SLIT and NTRK like family
Gene summary
This gene encodes an integral membrane protein that contains two N-terminal leucine-rich repeats domains and contains C-terminal regions similar to neurotrophin receptors. The encoded protein may play a role in modulating neurite activity. Alternatively spliced transcript variants encoding the same protein have been described.[provided by RefSeq, Feb 2010]
- SLITL1
- TMEM257
- CXorf1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
The *SLITRK2* gene encodes a transmembrane protein expressed at postsynaptic neurons that regulates neurite outgrowth and excitatory synapse formation. *SLITRK2* was first reported in relation to X‑linked complex neurodevelopmental disorder in 2022 (El Chehadeh et al., PMID: 35840571). Affected individuals present with global developmental delay, intellectual disability of variable severity, neuropsychiatric and behavioral problems (including anxiety, autism spectrum disorder, ADHD, and aggressive behavior), and motor abnormalities such as unsteady gait, spasticity, or dystonia. Additional findings in a subset of individuals include seizures, feeding difficulties, kyphoscoliosis, short stature, and nonspecific structural brain abnormalities. Eight variants (6 missense and 2 nonsense) that have been reported in seven males and one female in two publications (PMIDs: 35840571, 38283150) are included in this curation. *SLITRK2* has a single protein-coding exon, which is its last exon, and is not predicted to undergo nonsense-mediated decay. The variants were either *de novo* (in two probands) or inherited from an unaffected mother, suggestive of an X‑linked recessive pattern of inheritance. Functional studies showed that four missense variants and a nonsense variant resulting in a truncated protein had impaired membrane trafficking and/or impaired excitatory synapse-promoting effects (PMID: 35840571). Two missense variants with no evidence of altered function, a missense variant in a male proband with a likely pathogenic variant in *ARX*, and a *de novo* missense variant in a female reported three times in gnomAD, were scored 0 points. The mechanism of pathogenicity appears to be loss of function. *SLITRK2* is not strongly constrained for loss‑of‑function variation (pLI = 0.75, LOEUF = 0.58, gnomAD 4.1.1) or missense variants (Z = 2.76). This gene-disease relationship is also supported by a mouse model. *Slitrk2* conditional knockout mice exhibit memory deficits and abnormal gait, while hippocampal CA1-specific conditional knockout of Slitrk2 impaired excitatory synapse maintenance and caused abnormalities in spatial reference memory (PMID: 35840571). In summary, there is limited evidence to support the relationship between *SLITRK2* and X-linked complex neurodevelopmental disorder. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 2, 2025 (SOP Version 12).
Inheritance Pattern: XL
Disease ID:MONDO:0957203
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0957203
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLITRK2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_032539.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 11 | 2 | 20 | ||
| missense | 6 | 105 | 4 | 115 | ||
| nonsense | 1 | 7 | 8 | |||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 7 | 121 | 15 | 2 | 145 |
Highest pathogenic variant AF is 0.000003307179
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_115928.1 | 1 | MANE Select | |
| Ensembl | ENSP00000334374.5 | 1 | MANE Select | |
| RefSeq | NP_001137475.1 | 1 | Standard | |
| RefSeq | NP_001137476.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuronal System
- Receptor-type tyrosine-protein phosphatases
- Protein-protein interactions at synapses
Biological Process
- axonogenesis
- regulation of synapse organization
- positive regulation of synapse assembly
- synaptic membrane adhesion
- regulation of presynapse assembly
Cellular Component
- plasma membrane
- integral component of membrane
- glutamatergic synapse
- GABA-ergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000370490
- Coding exons
- 1
- Length
- 8011
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.20 | 212 | 323 | 0.656 | 0.0000247 | 5528 |
| Missense (PolyPhen) | 50 | 118.15 | 0.4232 | 2176 | ||
| Synonymous | -0.725 | 150 | 139 | 1.08 | 0.0000112 | 1724 |
| Loss of Function | 2.54 | 7 | 18.9 | 0.370 | 0.00000164 | 315 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: It is involved in synaptogenesis and promotes excitatory synapse differentiation (PubMed:27273464, PubMed:27812321). Suppresses neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q810C0, ECO:0000269|PubMed:27273464, ECO:0000269|PubMed:27812321}.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.279
- RVIS EVS
- -0.78
- RVIS percentile EVS
- 12.88
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.215
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |